Society of Nuclear Medicine

SHERPA: Unknown

People

  1. Humm
    Humm
  2. Zanzonico
    Zanzonico
  3. Schoder
    Schoder
  4. Lewis
    Lewis
  5. O'Donoghue
    O'Donoghue
  6. Blasberg
    Blasberg
  7. Morris
    Morris
  8. Scheinberg
    Scheinberg
  9. Beattie
    Beattie
  10. Gonen
    Gonen

Groups

  1. Radiology, Department of (695)
  2. Molecular Imaging and Therapy Service (572)
  3. GSK Faculty (476)
  4. Sloan Kettering Institute Faculty (387)
  5. Molecular Pharmacology and Chemistry Program Faculty (382)
  6. Medical Physics (295)
  7. Sloan Kettering Institute Postdocs (263)
  8. Department of Medicine (214)
  9. Radiochemistry and Imaging Sciences Service (209)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (180)
Search Within
Formats
  1. Journal Article (466)
  2. Meeting Abstract (410)
  3. Review (32)
  4. Editorial (25)
  5. Miscellaneous (6)
  6. Correspondence (5)
  7. Guidelines (3)
  8. Conference Paper (2)
  9. Research Letter (1)
Groups
  1. Radiology, Department of (695)
  2. Molecular Imaging and Therapy Service (572)
  3. GSK Faculty (476)
  4. Sloan Kettering Institute Faculty (387)
  5. Molecular Pharmacology and Chemistry Program Faculty (382)
  6. Medical Physics (295)

More Groups

People
  1. Steven Larson (294)
  2. John Humm (114)
  3. Ronald Finn (99)
  4. Pat Zanzonico (97)
  5. Heiko Schoder (95)
  6. Jason Lewis (89)

More People

Years
  1. 2025 (16)
  2. 2024 (51)
  3. 2023 (54)
  4. 2022 (24)
  5. 2021 (38)
  6. 2020 (47)

More Years

Publications
  1. Journal of Nuclear Medicine (950)

Results (950)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • An (18)F-FDG PET/CT and mean lung dose model to predict early radiation pneumonitis in stage III non-small cell lung cancer patients treated with chemoradiation and immunotherapy
    Journal Article

    Thor, M.; Lee, C.; Sun, L.; Patel, P.; Apte, A.; Grkovski, M.; Shepherd, A. F.; Gelblum, D. Y.; Wu, A. J.; Simone, C. B. 2nd; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Interrogating the theranostic capacity of a MUC16-targeted antibody for ovarian cancer
    Journal Article

    Mack, K. N.; Samuels, Z. V.; Carter, L. M.; Viray, T. D.; Mandleywala, K.; Brooks, C. L.; Hollingsworth, M. A.; Radhakrishnan, P.; Lewis, J. S.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Sequencing of somatostatin-receptor–based therapies in neuroendocrine tumor patients
    Review

    Strosberg, J. R.; Al-Toubah, T.; El-Haddad, G.; Lagunes, D. R.; Bodei, L.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Design considerations in the PSMAfore trial
    Editorial

    Sartor, O.; Fizazi, K.; Herrmann, K.; Morris, M. J.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • (212)Pb-pretargeted theranostics for pancreatic cancer
    Journal Article

    Bauer, D.; Carter, L. M.; Atmane, M. I.; De Gregorio, R.; Michel, A.; Kaminsky, S.; Monette, S.; Li, M.; Schultz, M. K.; Lewis, J. S.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • 89Zr-DFO-girentuximab PET/CT imaging can accurately detect clear cell renal cell carcinoma primary and secondary lesions in patients with renal masses at conventional imaging, results from ZIRCON phase 3 study
    Meeting Abstract

    Calais, J.; Shuch, B.; Pantuck, A.; Bernhard, J. C.; Morris, M.; Master, V.; Scott, A.; van Praet, C.; Bailly, C.; Aksoy, T.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Dose-escalation study of [225Ac]-FPI-1434 (FPI-1434) in patients (pts) with IGF-1R expressing advanced solid tumors: Preliminary pharmacology and dosimetry results
    Meeting Abstract

    Pandit-Taskar, N.; Wong, J.; Subbiah, V.; Chenard-Poirier, M.; Pryma, D.; Berlin, A.; Juergens, R.; Puzanov, I.; Jacene, H.; Schindler, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Individualized dosing for high-dose targeted radiation of hematopoietic cells with Iomab-B (I131-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia (R/R AML): Safety and efficacy results from the pivotal phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save

    • Society of Nuclear Medicine – authorized name for: